The tumor growth induced by FGF2 overexpression can be significantly inhibited by the VEGFR2 monoclonal antibody, indicating VEGF’s role as a downstream mediator in FGF2-induced angiogenesis [74,75]. Here, FGF2 is linked to neoplasm.